Jennifer K. Litton
- Oncology top 0.1%
- Cancer Research top 0.2%
- Molecular Biology top 2%
- Genetics top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Gabriel N. HortobágyiBanu ArunFunda Meric‐BernstamAna M. González-AnguloElizabeth A. MittendorfCarey K. AndersRebecca H. JohnsonArchie Bleyer
- Topics
- BRCA gene mutations in cancer (88 papers)Breast Cancer Treatment Studies (59 papers)PARP inhibition in cancer therapy (57 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Jennifer K. Litton
225 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 7.7k
- Cancer Research 3.8k
- Molecular Biology 3.2k
- Genetics 2.5k
- Pulmonary and Respiratory Medicine 2.4k
Countries citing papers authored by Jennifer K. Litton
This map shows the geographic impact of Jennifer K. Litton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer K. Litton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer K. Litton more than expected).
Fields of papers citing papers by Jennifer K. Litton
This network shows the impact of papers produced by Jennifer K. Litton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer K. Litton. The network helps show where Jennifer K. Litton may publish in the future.
Co-authorship network of co-authors of Jennifer K. Litton
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer K. Litton. A scholar is included among the top collaborators of Jennifer K. Litton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer K. Litton. Jennifer K. Litton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 45 | |
| 8 | 75 | |
| 9 | 25 | |
| 10 | 16 | |
| 11 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutationbreakdown → | 1401 |
| 12 | 40 | |
| 13 | 18 | |
| 14 | 8 | |
| 15 | 103 | |
| 16 | 48 | |
| 17 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppressionbreakdown → | 768 |
| 18 | PD-L1 Expression in Triple-Negative Breast Cancerbreakdown → | 1065 |
| 19 | 228 | |
| 20 | 80 |
About Jennifer K. Litton
Jennifer K. Litton is a scholar working on Cancer Research, Oncology and Genetics, having authored 238 papers that have together received 11.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (88 papers), Breast Cancer Treatment Studies (59 papers) and PARP inhibition in cancer therapy (57 papers). The work is most often cited by research in Oncology (7.7k citations), Cancer Research (3.8k citations) and Genetics (2.5k citations). Jennifer K. Litton has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Gabriel N. Hortobágyi, Banu Arun, Funda Meric‐Bernstam, Ana M. González-Angulo, Elizabeth A. Mittendorf, Carey K. Anders, Rebecca H. Johnson, Archie Bleyer, Hope S. Rugo and Marianne Phillips. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.